Beautiful Virgin Islands

Monday, Nov 03, 2025

Boris Johnson Says He Will Have AstraZeneca Vaccine, Dismisses Safety Fears

Boris Johnson Says He Will Have AstraZeneca Vaccine, Dismisses Safety Fears

"I finally got news and I've got to have my own jab, very shortly, I'm pleased to discover. It will certainly be Oxford AstraZeneca, that I will be having," Boris Johnson said .

British Prime Minister Boris Johnson said on Wednesday he will take the vaccine developed by AstraZeneca after a number of European countries halted their rollout of the jab over safety fears.

Johnson dismissed questions in parliament about why several countries had suspended use of the product developed by the British-Swedish pharmaceutical company with scientists at Oxford University.

But he told lawmakers: "I finally got news and I've got to have my own jab, very shortly, I'm pleased to discover.

"It will certainly be Oxford AstraZeneca, that I will be having."

Johnson, 56, is among the next category of people being called for vaccination. The government hopes to have offered it to all adults by July.

Health Secretary Matt Hancock said that timeline remains on track, despite the National Health Service in England warning in a letter to administrators that vaccine supplies will be "significantly constrained" from March 29 for up to a month.

"Vaccine supply is always lumpy and we regularly send out technical letters to the NHS to explain the ups and downs of the supply over the future weeks," Hancock told a news conference, insisting the letter was "standard" practice.

Britain has now given more than 25 million people a first dose of a Covid vaccine -- including 11 million doses of the AstraZeneca jab -- after starting a mass inoculation programme in December last year.

It is also using a jab developed by Pfizer/BioNTech in its rollout programme but recipients do not normally get a choice of vaccines.

Johnson wrote in the Times newspaper that the AstraZeneca vaccine "is safe and works extremely well". Hancock and England's deputy chief medical officer Jonathan Van-Tam echoed that assurance at the press conference.

- Royal intervention -


European countries including France, Spain and Germany are among those who have halted using the jab pending a review by the European Medicines Agency (EMA) amid feared links to blood clots and brain haemorrhages.

Queen Elizabeth II's oldest son and heir, Prince Charles, on Wednesday criticised opposition to coronavirus vaccines.

"Who would have thought, for instance, that in the 21st century that there would be a significant lobby opposing vaccination, given its track record in eradicating so many terrible diseases," he said in an article in the Future Healthcare Journal.

Charles, who has been vocal in advocating the rollout of the vaccine among more reluctant minority communities in Britain, added that the jab had the "potential to protect and liberate some of the most vulnerable in our society from coronavirus".

The 72-year-old Prince of Wales tested positive for coronavirus last year and suffered mild symptoms. He had his first dose of a vaccine in February.

His wife, Camilla, 73, confirmed on Tuesday she had been given the AstraZeneca shot.

"You take what you are given," she said as the couple visited a vaccination centre at a north London mosque, adding that she had suffered no ill-effects.

- 'No evidence' -


Professor Jeremy Brown, from the government's Joint Committee on Vaccination and Immunisation (JCVI), said suspension of the AstraZeneca jab was "not logical".

"There is the concern that what's happening in Europe might make people in the UK less confident in the AstraZeneca vaccine," he told broadcaster ITV.

The EMA, the World Health Organization and Britain's Medicines and Healthcare products Regulatory Agency have all backed the AstraZeneca jab.

France and Italy have said they will "promptly restart" giving the jab if the EMA review allows it.

As Britain has surged ahead with its vaccination programme, European countries have been accused of playing politics to distract from their sluggish inoculation rollouts.

European leaders were angered in January after AstraZeneca announced it was unable to deliver the agreed numbers of jabs to the bloc.

Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
UK Labour Peer Warns of Emerging ‘Constituency for Hating Jews’ in Britain
UK Home Secretary Admits Loss of Border Control, Warns Public Trust at Risk
President Trump Expresses Sympathy for UK Royal Family After Title Stripping of Prince Andrew
Former Prince Andrew to Lose His Last Military Title as King Charles Moves to End His Public Role
King Charles Relocates Andrew to Sandringham Estate and Strips Titles Amid Epstein Fallout
Two Arrested After Mass Stabbing on UK Train Leaves Ten Hospitalised
Glamour UK Says ‘Stay Mad Jo x’ After Really Big Rowling Backlash
Former Prince Prince Andrew Faces Possible U.S. Congressional Appearance Over Jeffrey Epstein Inquiry
UK Faces £20 Billion Productivity Shortfall as Brexit’s Impact Deepens
UK Chancellor Rachel Reeves Eyes New Council-Tax Bands for High-Value Homes
UK Braces for Major Storm with Snow, Heavy Rain and Winds as High as 769 Miles Wide
U.S. Secures Key Southeast Asia Agreements to Reshape Rare Earth Supply Chains
US and China Agree One-Year Trade Truce After Trump-Xi Talks
BYD Profit Falls 33 % as Chinese EV Maker Doubles Down on Overseas Markets
US Philanthropists Shift Hundreds of Millions to UK to Evade Regulatory Uncertainty in Trump Era
Israeli Energy Minister Delays $35 Billion Gas Export Agreement with Egypt
King Charles Strips Prince Andrew of Titles and Royal Residence
Trump–Putin Budapest Summit Cancelled After Moscow Memo Raises Conditions for Ukraine Talks
Amazon Shares Soar 11% as Cloud Business Hits Fastest Growth Since 2022
Credit Markets Flooded with More Than $200 Billion of AI-Linked Debt Issuance
U.S. Treasury Secretary Scott Bessent Says China Made 'a Real Mistake' by Threatening Rare-Earth Exports
Report Claims Nearly Two Billion Dollars in Foreign Charity Funds Flowed into U.S. Advocacy Groups
White House Refutes Reports That US Targeting Military Sites in Venezuela
Meta Seeks Dismissal of Strike 3’s $350 Million Copyright Lawsuit
Apple Exceeds Forecasts With $102.5 Billion Q3 Revenue Despite iPhone Miss
Israel's IDF Major General Yifat Tomer-Yerushalmi Admits to Act Amounting to Aiding Hamas During Wartime (Treason)
Shawbrook IPO Marks London’s Biggest UK Listing in Two Years
UK Government Split Over Backing Brazil’s $125 Billion Tropical Forest Fund Ahead of COP30
J.K. Rowling Condemns Glamour UK Feature of Nine Trans Women as 'Men Better at Being Women'
King Charles III Removes Prince Andrew’s Titles and Orders His Departure from Royal Lodge
UK Finance Minister Reeves Releases Email Correspondence to Clarify Rental-Licence Breach
UK and Vietnam Sign Landmark Migration Deal to Fast-Track Returns of Irregular Arrivals
UK Drug-Pricing Overhaul Essential for Life-Sciences Ambition, Says GSK Chief
Princesses Beatrice and Eugenie Temporarily Leave the UK Amid Their Parents’ Royal Fallout
UK Weighs Early End to Oil and Gas Windfall Tax as Reeves Seeks Investment Commitments
UK Retail Inflation Slows as Shop Prices Fall for First Time Since Spring
Next Raises Full-Year Profit Guidance After Strong Third-Quarter Performance
Reform UK’s Lee Anderson Admits to 'Gaming' Benefits System While Advocating Crackdown
United States and South Korea Conclude Major Trade Accord Worth $350 Billion
Hurricane Melissa Strikes Cuba After Devastating Jamaica With Record Winds
Vice President Vance to Headline Turning Point USA Campus Event at Ole Miss
U.S. Targets Maritime Narco-Routes While Border Pressure to Mexico Remains Limited
Bill Gates at 70: “I Have a Real Fear of Artificial Intelligence – and Also Regret”
Elon Musk Unveils Grokipedia: An AI-Driven Alternative to Wikipedia
Saudi Arabia Unveils Vision for First-Ever "Sky Stadium" Suspended Over Desert Floor
Amazon Announces 14 000 Corporate Job Cuts as AI Investment Accelerates
UK Shop Prices Fall for First Time Since March, Food Leads the Decline
London Stock Exchange Group ADR (LNSTY) Earns Zacks Rank #1 Upgrade on Rising Earnings Outlook
Soap legend Tony Adams, long-time star of Crossroads, dies at 84
Rachel Reeves Signals Tax Increases Ahead of November Budget Amid £20-50 Billion Fiscal Gap
×